Lindsay Lambert

Lindsay Lambert serves as the Director of Clinical Operations at FidoCure®, where she leverages her expertise in veterinary oncology to advance the application of targeted therapies in treating canine cancers. She plays a crucial role in collaborating with veterinarians to address a wide array of cancers, including hemangiosarcoma, bladder cancer, and rare types like histiocytic sarcoma. Lambert is instrumental in providing DNA testing services that pinpoint genetic markers crucial for customizing cancer treatment for each dog. Through her efforts, FidoCure® facilitates access to specialized medicine via a network of partner compounding pharmacies. She has been pivotal in expanding FidoCure®’s reach by fostering relationships with veterinarians across various states, significantly enhancing the company’s impact. Additionally, Lambert has contributed to the collection of over 1.7 billion data points on canine cancer, which aids in the research and development of more effective treatments. Her work has also led to the publication of three peer-reviewed papers that underscore the effectiveness of precision medicine in improving patient outcomes. Currently, her initiatives support the treatment of nearly 5,000 pet dogs battling cancer, underscoring her commitment to enhancing veterinary care through innovative approaches.